Aspiriant Holdings S3’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-22,819
Closed -$867K 107
2015
Q2
$867K Sell
22,819
-433
-2% -$16.2K 0.35% 76
2015
Q1
$865K Buy
23,252
+2,513
+12% +$95.3K 0.34% 73
2014
Q4
$826K Buy
20,739
+1,952
+10% +$76K 0.34% 78
2014
Q3
$732K Buy
18,787
+1,454
+8% +$59.1K 0.29% 77
2014
Q2
$681K Buy
17,333
+635
+4% +$25.4K 0.27% 79
2014
Q1
$667K Buy
16,698
+5,532
+50% +$207K 0.28% 80
2013
Q4
$422K Buy
+11,166
New +$405K 0.17% 88

Other funds holding BAX

Aspiriant Holdings S3's BAX Position: Q3 2015 in Review

Aspiriant Holdings S3 sold out of Baxter International (BAX) in Q3 2015, closing a stake of 22,819 shares — an estimated $867K sold.

Aspiriant Holdings S3 first reported a position in BAX in Q4 2013 and held it in 7 quarters. The position peaked at $867K in Q2 2015. 888 funds tracked by Wall St. Rank hold BAX as of Q3 2015.

  • Aspiriant Holdings S3 reported no remaining Baxter International position as of Q3 2015 after selling out during the quarter.
  • Aspiriant Holdings S3 sold 22,819 Baxter International shares in Q3 2015, an estimated $867K.
  • Aspiriant Holdings S3 first reported a position in Baxter International in Q4 2013 and held it in 7 quarters.
  • Aspiriant Holdings S3's Baxter International position peaked at $867K in Q2 2015.
  • 888 funds tracked by Wall St. Rank held Baxter International as of Q3 2015.

Based on Aspiriant Holdings S3's 13F filing for Q3 2015, filed 23 Oct 2015.